Cost Effectiveness of Treatment for Benign Prostatic Hyperplasia: An Economic Model for Comparison of Medical, Minimally Invasive, and Surgical Therapy-Reference-Cited by-同舟云学术

Cost Effectiveness of Treatment for Benign Prostatic Hyperplasia: An Economic Model for Comparison of Medical, Minimally Invasive, and Surgical Therapy

Published:2002-02 Issue:1 Volume:16 Page:51-56
ISSN:0892-7790
Container-title:Journal of Endourology
language:en
Short-container-title:Journal of Endourology

Author:

Manyak Michael J.¹,Ackerman Stacey J.²,Blute Michael L.³,Rein Alison L.²,Buesterien Kathleen²,Sullivan Erin M.²,Tanio Craig P.⁴,Strauss Michael J.²

Affiliation:

1. Department of Urology, The George Washington University Medical Center, Washington, DC.

2. Covance Health Economics and Outcome Services, Washington, DC

3. The Mayo Clinic Foundation, Rochester, Minnesota

4. The Johns Hopkins Hospital, Baltimore, Maryland

Publisher

Mary Ann Liebert Inc

Subject

Urology

Link

http://www.liebertpub.com/doi/pdf/10.1089/089277902753483736

Reference20 articles.

1. Medical outcomes research and benign prostatic hyperplasia

2. A Comparison of Transurethral Surgery with Watchful Waiting for Moderate Symptoms of Benign Prostatic Hyperplasia

3. Watchful waiting vs immediate transurethral resection for symptomatic prostatism. The importance of patients' preferences

4. Economic modeling to assess the costs of treatment with finasteride, terazosin, and transurethral resection of the prostate for men with moderate to severe symptoms of benign prostatic hyperplasia

5. Transurethral Prostatectomy: Immediate and Postoperative Complications. A Cooperative Study of 13 Participating Institutions Evaluating 3,885 Patients

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Exploring pharmacological interventions in benign prostate hyperplasia: the role of cost-effectiveness analysis in daily practice and future directions;Expert Opinion on Pharmacotherapy;2024-05-02

2. Determining health-related quality of life and health state utility values of recurrent urinary tract infections in women;International Urogynecology Journal;2023-02-08

3. Economic Evaluation for Benign Prostatic Hyperplasia in Iran: Surgical Treatment or Dutasteride;IRAN J PHARM RES;2020

4. Pharmacotherapy vs surgery as initial therapy for patients with moderate-to-severe benign prostate hyperplasia: a cost-effectiveness analysis;BJU International;2018-09-11

5. Minimally Invasive Treatment Algorithm for Benign Prostatic Hyperplasia;Endoscopic Diagnosis and Treatment in Prostate Pathology;2016